Literature DB >> 28224664

Gemcitabine and docetaxel as a novel treatment regimen for blastic plasmacytoid dendritic cell neoplasm.

Matthew L Ulrickson1,2, Akshjot Puri3, Sarah Lindstrom1, Ryan D Cassaday4,5, Nicolas De Padova1, Pamela S Becker4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28224664     DOI： 10.1002/ajh.24696

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  4 in total

Review 1.  Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Daniel Kerr; Ling Zhang; Lubomir Sokol
Journal:  Curr Treat Options Oncol       Date:  2019-02-04

Review 2.  Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

Authors:  Minas P Economides; David Rizzieri; Naveen Pemmaraju
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

Review 3.  Clinical Insights into the Management of Blastic Plasmacytoid Dendritic Cell Neoplasm.

Authors:  Yumeng Zhang; Lubomir Sokol
Journal:  Cancer Manag Res       Date:  2022-06-28       Impact factor: 3.602

4.  Exploring the effect of chidamide on blastic plasmacytoid dendritic cell neoplasm: a case report and literature review.

Authors:  Shunan Wang; Wei Guo; Xin Wan; Yongliang Teng; Xiaoge Zhou; Ou Bai
Journal:  Ther Clin Risk Manag       Date:  2018-01-03       Impact factor: 2.423
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.